Literature DB >> 16020112

Successful management of congenital dyserythropoietic anemia type I with interferon alpha in a child.

Neşe Yarali1, Tunç Fişgin, Feride Duru, Pergin Atilla, Sevda F Müftüoğlu, S F Kaymaz.   

Abstract

Congenital dyserythropoietic anemia type I (CDA I) is a rare inherited hematological disorder characterized by macrocytic anemia and ineffective erythropoiesis with pathognomonic morphological features that include internuclear chromatin bridges, spongy heterochromatin, and invagination of the cytoplasm into the nuclear area in erythroid precursors. Treatment of anemia with the usual hematinics is without effect and 15% of patients need chronic transfusions. Successful treatment of CDA I with interferon-alpha was noted. The authors report a patient with CDA I who had required transfusions every 2-3 months since the neonatal period and responded to recombinant interferon-alpha therapy with the findings of electron microscopic investigations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16020112     DOI: 10.1080/08880010590935149

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  2 in total

1.  Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha.

Authors:  Ayse Salihoglu; Tugrul Elverdi; Ahmet Emre Eskazan; Deniz Eyice; Isil Bavunoglu; Muhlis Cem Ar; Seniz Ongoren; Elif Guzel; Zafer Baslar; Aydin Tunckale; Nukhet Tuzuner; Teoman Soysal
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-21       Impact factor: 0.900

2.  Response to Alpha-Interferon Treatment of the Congenital Dyserythropoietic Anemia type I in Two Sicilian Beta Thalassemia Carriers.

Authors:  V Agrigento; R Barone; S Sclafani; R Di Maggio; M Sacco; A Maggio; E D'Alcamo
Journal:  Indian J Hematol Blood Transfus       Date:  2016-12-18       Impact factor: 0.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.